The Seventeenth International Conference on Endothelin (ET-17).
The Seventeenth International Conference on Endothelin (ET-17).
复制标题
第十七届国际内皮素会议(ET-17)。
DOI:
10.1139/cjpp-2022-0091
复制
发表时间:
2022
影响因子:
2.1
通讯作者:
Hyndman,KellyA
中科院分区:
文献类型:
--
作者:
Gumz,MichelleL;Hyndman,KellyA
The Seventeenth International Conference on Endothelin (ET-17) was held during 4–7 October 2021 and because of the SARS-CoV-2 pandemic it was held virtually. Sponsored by the American Physiological Society, ET-17 was held over 4 half-days, with exciting studies related to all organ systems presented. Since theLancetarticle reporting the successful SONAR clinical trial with endothelin receptor A blockade in diabetic nephropathy, there has been renewed interest in the use of endothelin receptor antagonists in the treatment of a variety of diseases. From the rigorous preclinical studies to the latest clinical trials, ET-17 was full of exciting science, some of which is reported in this special issue. We welcomed new labs to the meeting and everyone left with the impression that ET-related research is a vibrant field with very significant discoveries being made.
影响因子:
6.1
作者:
D. Pollock;A. Gulati;A. Ergul
通讯作者:
A. Ergul
影响因子:
19.6
作者:
Ebefors, Kerstin;Wiener, Robert J.;Daehn, Ilse
通讯作者:
Daehn, Ilse
影响因子:
2.1
作者:
B. Widyantoro;N. Emoto
通讯作者:
N. Emoto